You are here: Industry Insights > Novartis

News List

English court backs NHS in fight with Bayer, Novartis over off-label Avastin use fiercepharma
September 25, 2018
After a long legal fight with Bayer and Novartis, England’s National Health Service has won the right to use a compounded form of Roche’s Avastin off-label in patients with wet age-related macular degeneration over much ...
Amsterdam fiercepharma
September 21, 2018
After more than 50 years in Arnhem, the Netherlands, Novartis has decided to move its Dutch operations to Amsterdam, the new home of the European Medicines Agency (EMA).
Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected pharmafile
September 20, 2018
Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, according to Dutch regional public...
NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma pharmatimes
September 20, 2018
The National Institute for Health and Care Excellence has turned down NHS funding for use of Novartis’ CAR-T therapy Kymriah in adults...
Novartis moving 400 employees to Amsterdam fiercepharma
September 20, 2018
After more than 50 years in Arnhem, the Netherlands, Novartis has decided to move its Dutch operations to Amsterdam, the new home of the European Medicines Agency (EMA).
NICE nod for Novartis’ targeted skin cancer combo pharmatimes
September 18, 2018
The National Institute for Health and Care Excellence has backed NHS funding for Novartis’ oral targeted adjuvant combination therapy...
Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in fiercepharma
September 14, 2018
As Hurricane Florence bore down on the southeast today, drugmakers were taking steps to keep medicine supplies flowing and employees out of harms way.
Novartis to sell Sandoz assets to Aurobindo for $900m pharmatimes
September 13, 2018
Novartis is selling parts of its generics business Sandoz to Aurobindo in a deal worth at least $900 million.
Alcon Confirms Commitment to Switzerland Ahead of Proposed Spinoff from Novartis americanpharmaceuticalreview
September 13, 2018
Alcon has announced plans to locate its future global headquarters in the Canton of Geneva, Switzerland, following completion of its proposed spinoff from Novartis.
Mundipharma, Novartis to distribute pain medicine in SE Asia biospectrum
September 12, 2018
Novartis will retain all international development responsibility, as well as clinical development activities.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 71 72 Next page